Minerva Neurosciences
NERV
#8685
Rank
โ‚น24.75 B
Marketcap
โ‚น518.40
Share price
8.60%
Change (1 day)
151.65%
Change (1 year)

Earnings for Minerva Neurosciences (NERV)

Earnings in 2026 (TTM): -โ‚น37.72 Billion

According to Minerva Neurosciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น28.02 Billion a decrease over its 2024 earnings that were of โ‚น0.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Minerva Neurosciences from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น37.72 Billion34.62%
2025 -โ‚น28.02 Billion-20492.68%
2024 โ‚น0.13 B-104.8%
2023 -โ‚น2.87 Billion-6.55%
2022 -โ‚น3.07 Billion-37.91%
2021 -โ‚น4.94 Billion-2764.37%
2020 โ‚น0.18 B-102.61%
2019 -โ‚น7.11 Billion48.37%
2018 -โ‚น4.79 Billion22.67%
2017 -โ‚น3.91 Billion31.74%
2016 -โ‚น2.97 Billion14.64%
2015 -โ‚น2.59 Billion-52.41%
2014 -โ‚น5.44 Billion1644.37%
2013 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Incyte
INCY
โ‚น169.35 B-527.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-โ‚น3.24 Billion-91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น20.76 Billion-47.62%๐Ÿ‡บ๐Ÿ‡ธ USA